Skip to main content
. Author manuscript; available in PMC: 2018 Aug 13.
Published in final edited form as: J Urol. 2017 Aug 12;199(1):215–222. doi: 10.1016/j.juro.2017.07.087

Table 2.

Non-UI LUTS at baseline and after 6 months by treatment group, amount of weight loss at 6 months and amount of exercise at 6 months.

Intervention Control
Baseline 6 months Baseline 6 months Net* Effect
Daytime Frequency 109 (48%) 93 (43%) 63 (56%) 47 (52%) −1%
Nocturia 112 (50%) 83 (38%) 61 (54%) 47 (48%) −6%
Urinary Urgency 138 (61%) 89 (40%) 71 (63%) 46 (47%) −5%
IPSS Score ≥ 8 137 (61%) 76 (35%) 72 (64%) 40 (41%) −3%
Weight loss <5%+no change+increase Weight loss >=5%
Daytime frequency 72 (50%) 56 (43%) 100 (51%) 84 (49%) 5%
Nocturia 73 (51%) 58 (41%) 100 (51%) 72 (41%) 0%
Urinary Urgency 87 (61%) 66 (46%) 122 (63%) 69 (39%) −9%
IPSS Score ≥ 8 89 (62%) 57 (40%) 120 (62%) 59 (34%) −6%
< 1500 kilocalories/week Paffenbarger Score >= 1500 kilocalories/week Paffenbarger Score
Daytime frequency 93 (50%) 79 (44%) 62 (50%) 57 (48%) 4%
Nocturia 99 (53%) 73 (39%) 58 (47%) 51 (41%) 8%
Urinary Urgency 117 (63%) 87 (47%) 69 (56%) 44 (36%) −4%
IPSS Score ≥ 8 117 (63%) 72 (39%) 72 (59%) 39 (32%) −3%

Reported as number (percent of total)

Daytime frequency = 8 or greater voids during waking hours

Nocturia = 2 or greater voids at night

Net effect compares the percent improvement of non-UI LUTS by treatment group, amount of weight loss at 6 months and amount of exercise at 6 months

*

None of the net effect comparisons reached statistical significance.

**

Numbers in groups differ based on completeness of follow-up.